Announcements
- Immuron Limited to Present at the Emerging Growth Conference
- Immuron Director Resignation
- Immuron to host Live Virtual Event
- Immuron Travelan® sales continued strong growth
- Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
- Immuron Presentation Australian Biologics Festival 2024
- Immuron achieves record Travelan® sales
- Immuron CEO, Steven Lydeamore Investor Webinar Presentation
- Immuron achieves record half yearly Travelan® sales
- Immuron Clinical Trials Update
More ▼
Key statistics
As of last trade, Immuron Ltd (ANWA:FRA) traded at 1.99, 54.26% above the 52 week low of 1.29 set on Nov 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.99 |
---|---|
High | 1.99 |
Low | 1.99 |
Bid | 1.98 |
Offer | 2.38 |
Previous close | 2.04 |
Average volume | 0.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of May 23 2024 07:23 BST.
More ▼